CoChat

Launching the C-HPP neXt-CP50 Pilot Project for Functional Characterization of Identified Proteins with No Known Function

Open access
Paik, Young-Ki, Lane, Lydie, Kawamura, Takeshi, Chen, Yu-Ju, Cho, Je-Yoel, LaBaer, Joshua, Yoo, Jong Shin, Domont, Gilberto, Corrales, Fernando, Omenn, Gilbert S., Archakov, Alexander, Encarnación-Guevara, Sergio, Lui, Siqi, Salekdeh, Ghasem Hosseini, Cho, Jin-Young, Kim, Chae-Yeon, Overall, Christopher M. · 2018 · Journal of Proteome Research
Cited by 49

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

An important goal of the Human Proteome Organization (HUPO) Chromosome-centric Human Proteome Project (C-HPP) is to correctly define the number of canonical proteins encoded by their cognate open reading frames on each chromosome in the human genome. When identified with high confidence of protein evidence (PE), such proteins are termed PE1 proteins in the online database resource, neXtProt. However, proteins that have not been identified unequivocally at the protein level but that have other evidence suggestive of their existence (PE2-4) are termed missing proteins (MPs). The number of MPs has been reduced from 5511 in 2012 to 2186 in 2018 (neXtProt 2018-01-17 release). Although the annotation of the human proteome has made significant progress, the "parts list" alone does not inform function. Indeed, 1937 proteins representing ∼10% of the human proteome have no function either annotated from experimental characterization or predicted by homology to other proteins. Specifically, these 1937 "dark proteins" of the so-called dark proteome are composed of 1260 functionally uncharacterized but identified PE1 proteins, designated as uPE1, plus 677 MPs from categories PE2-PE4, which also have no known or predicted function and are termed uMPs. At the HUPO-2017 Annual Meeting, the C-HPP officially adopted the uPE1 pilot initiative, with 14 participating international teams later committing to demonstrate the feasibility of the functional characterization of large numbers of dark proteins (CP), starting first with 50 uPE1 proteins, in a stepwise chromosome-centric organizational manner. The second aim of the feasibility phase to characterize protein (CP) functions of 50 uPE1 proteins, termed the neXt-CP50 initiative, is to utilize a variety of approaches and workflows according to individual team expertise, interest, and resources so as to enable the C-HPP to recommend experimentally proven workflows to the proteome community within 3 years. The results from this pilot will not only be the cornerstone of a larger characterization initiative but also enhance understanding of the human proteome and integrated cellular networks for the discovery of new mechanisms of pathology, mechanistically informative biomarkers, and rational drug targets.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/acs.jproteome.8b00383

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 44

  1. 10.12688/f1000research.11119.1 · DOI
  2. 10.1074/mcp.O111.009993 · DOI
  3. 10.1038/nbt.2152 · DOI · Paper page
  4. 10.1021/pr200824a · DOI · Paper page
  5. 10.1021/acs.jproteome.8b00441 · DOI · Paper page
  6. 10.1101/gr.226050.117 · DOI
  7. 10.1021/acs.chemrev.7b00120 · DOI · Paper page
  8. 10.1002/pmic.201500043 · doi:10.1002/pmic.201500043
  9. 10.1021/acs.jproteome.7b00851 · DOI · Paper page
  10. 10.1021/acs.analchem.7b04221 · DOI
  11. 10.1021/acs.jproteome.5b00785 · DOI
  12. 10.1016/j.chembiol.2013.04.008 · DOI
  13. 10.1101/gr.134767.111 · DOI · Paper page
  14. 10.7554/eLife.03523 · DOI · Paper page
  15. 10.1080/14789450.2017.1394189 · DOI
  16. 10.1021/acs.jproteome.7b00734 · DOI
  17. 10.1021/pr301183a · DOI · Paper page
  18. 10.1021/acs.jproteome.7b00375 · DOI
  19. 10.1021/pr301012j · DOI · Paper page
  20. Delgado A. P., 2014, Cancer Res., 11, 201
  21. 10.1002/prot.22024 · DOI
  22. 10.1038/464828a · DOI
  23. 10.1073/pnas.1508380112 · DOI · Paper page
  24. 10.1186/s13040-017-0144-6 · DOI
  25. 10.1021/acs.jproteome.6b00392 · DOI · Paper page
  26. 10.1021/acs.jproteome.7b00085 · DOI
  27. 10.1021/acs.jproteome.7b00146 · DOI
  28. 10.1093/nar/gkh052 · DOI · Paper page
  29. 10.1074/jbc.R110.174052 · DOI · Paper page
  30. 10.1038/nature11247 · DOI · Paper page
  31. 10.1126/science.1260419 · DOI · Paper page
  32. 10.1093/nar/gkw880 · DOI · Paper page
  33. 10.1007/978-1-60761-444-9_19 · DOI · Paper page
  34. 10.1038/srep10889 · DOI
  35. 10.1038/ng.2764 · DOI · Paper page
  36. 10.1093/database/bar026 · DOI · Paper page
  37. 10.1158/2159-8290.CD-13-0219 · DOI · Paper page
  38. 10.1128/MCB.01047-14 · DOI
  39. 10.1038/s41586-018-0124-0 · DOI · Paper page
  40. 10.1126/science.1225829 · DOI · Paper page
  41. 10.1371/journal.pone.0052877 · DOI
  42. 10.1007/s10969-015-9194-5 · DOI
  43. 10.1371/journal.pone.0086476 · DOI
  44. 10.1021/acs.jproteome.8b00453 · DOI · Paper page

Cited by

See all 49

Metadata

Authors
Paik, Y.-K., Lane, L., Kawamura, T., Chen, Y.-J., Cho, J.-Y., LaBaer, J., Yoo, J. S., Domont, G., Corrales, F., Omenn, G. S., Archakov, A., Encarnación-Guevara, S., Lui, S., Salekdeh, G. H., Cho, J.-Y., Kim, C.-Y., & Overall, C. M.
Venue
Journal of Proteome Research
Published
2018-10-01
Volume
17
Issue
12
Pages
4042-4050
ISSN
  • 1535-3893 (ISSN-L)
  • 1535-3907
OpenAlex
W2894829610
Cited by
49
References
12
FWCI
3.29
Type
journal article
Language
en
Open access
green
Funders
  • National Institute of Environmental Health Sciences (P30 ES017885)
  • Canadian Institutes of Health Research (FDN-148408)
  • National Cancer Institute (U24 CA210967)
  • Ministry of Health and Welfare (HI16C0257, HI13C2098)
  • Swiss Institute of Bioinformatics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.